About
Cell Therapy CDMO
Areas of Focus
Categories
Southeastern U.S.
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
2
As Collaborator
8
Total Enrollment
2,897
By Phase
NA: 6PHASE1/PHASE2: 1PHASE2: 1
By Status
COMPLETED: 6UNKNOWN: 3ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05105802Collaborator
Mindfulness-Based Intervention for Mild Traumatic Brain Injury
NACompleted
99 participants
Started: Oct 4, 2022 · Completed: Jul 6, 2024
NCT05028179Collaborator
PROTEUS: Evaluating the Use of Artificial Intelligence to Support Stress Echocardiography Testing for Heart Disease
NAActive, not recruiting
2,338 participants
Started: Nov 8, 2021 · Completed: Dec 31, 2023
NCT05378243Collaborator
Innovative Robotic Gait Trainer Use to Enable Walking in Children With Cerebral Palsy GMFCS III and IV
NAUnknown
10 participants
Started: Nov 8, 2021 · Completed: Jul 31, 2024
NCT04398303Lead Sponsor
ACT-20 in Patients With Severe COVID-19 Pneumonia
PHASE1/PHASE2Unknown
70 participants
Started: May 31, 2020 · Completed: Oct 31, 2020
NCT04061642Lead Sponsor
A Feasibility Study of an AI-Powered Clinical Decision Aid for Personalized Depression Treatment Selection
NACompleted
17 participants
Started: Dec 16, 2019 · Completed: Dec 31, 2020
Locations (1)
Headquarters
Orlando, FL, United States
Map
Loading map...